WuXi AppTec Co., Ltd. (SHA: 603259)

Market Cap	110.14B
Revenue (ttm)	38.71B
Net Income (ttm)	8.53B
Shares Out	2.91B
EPS (ttm)	2.90
PE Ratio	13.38
Forward PE	10.98
Dividend	0.99 (2.55%)
Ex-Dividend Date	Jun 26, 2024

Volume	19,939,377
Open	39.66
Previous Close	39.66
Day's Range	38.78 - 39.72
52-Week Range	36.36 - 93.56
Beta	0.73
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 25, 2024

About WuXi AppTec

WuXi AppTec Co., Ltd., an investment holding company, provides research and manufacturing services to discover, develop, and manufacture spectrum for small molecule drugs and advanced therapies in the People’s Republic of China, the United States, Europe, and internationally. The company operates in six segments: WuXi Chemistry, WuXi Testing, WuXi Biology, WuXi ATU, WuXi DDSU, and Others. It offers contract research, development, and manufacturing organization services for new drug development from discovery to commercial covering various categ...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 2000
• Employees: 41,116
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 603259

Financial Performance

In 2023, 603259's revenue was 40.34 billion, an increase of 2.51% compared to the previous year's 39.35 billion. Earnings were 9.61 billion, an increase of 9.00%.